Healthcare -
Biotechnology - NASDAQ - US
$ 4.87
2.31 %
$ 282 M
Market Cap
-3.83
P/E
RZLT - COST OF REVENUE
Cost of Revenue RZLT - Rezolute, Inc.
36 K
LAST VALUE
-62.50%
2 YEAR CAGR
-5.59%
5 YEAR CAGR
-34.28%
10 YEAR CAGR